The cytotoxic effect,cell cycle perturbations and apoptosis by gemcitabine in human bladder cancer lines
Tang Xiaoda
Abstract
Tang Xiaoda
Abstract
Background and purpose:Gemcitabine is effective as single-agent in the treatment of bladder cancer,but the mechanisms for the induction of apoptosis by gemcitabine is not clear.This study was aimed at determining the molecular mechanisms and the efficacy of gemcitabine.Methods:BIU-87,5637,T24 and EJ bladder cancer cell lines were cultured.The cytotoxic activity and apoptosis were analyzed by MTT and Annexin-V assay as well as DNA cytometry,respectively.The effects on the cell cycle were assessed by flow cytometry of propidium iodide.The expressions of genes of bcl-2,bax,p53 and Caspase3 were determined by flow cytometry immunofluorescence.Results:Gemcitabine inhibited cell proliferation in dose dependent manner.G_(2)/M arrest(83.94% and 85.46%) could be observed,especially obvious 5637 and EJ cell lines,after cell incubation with gemcitabine.The apoptosis percentages were 4.8%,11.7%,23.3% 12 hr,24 hr and 48 hr after 5637 cells exposure to 1μg/ml gemcitabine.The expressions of p53 and bcl-2 were not influenced,whereas the expressions of bax and Caspase3 were increased in a time-dependent manner after cells exposure to gemcitabine.The Annexin-V positive cells were significantly increased in dose-dependent way.Conclusions:Gemcitabine could inhibit cell proliferation,especially bladder cancer cells with the phenotype of low grade and shorter doubling time.Gemcitabine could arrest cells at G2/M phase and induce apoptosis possibly through the pathway of bcl-2/bax in bladder cancer cell lines.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background and purpose:Gemcitabine is effective as single-agent in the treatment of bladder cancer,but the mechanisms for the induction of apoptosis by gemcitabine is not clear.This study was aimed at determining the molecular mechanisms and the efficacy of gemcitabine.Methods:BIU-87,5637,T24 and EJ bladder cancer cell lines were cultured.The cytotoxic activity and apoptosis were analyzed by MTT and Annexin-V assay as well as DNA cytometry,respectively.The effects on the cell cycle were assessed by flow cytometry of propidium iodide.The expressions of genes of bcl-2,bax,p53 and Caspase3 were determined by flow cytometry immunofluorescence.Results:Gemcitabine inhibited cell proliferation in dose dependent manner.G_(2)/M arrest(83.94% and 85.46%) could be observed,especially obvious 5637 and EJ cell lines,after cell incubation with gemcitabine.The apoptosis percentages were 4.8%,11.7%,23.3% 12 hr,24 hr and 48 hr after 5637 cells exposure to 1μg/ml gemcitabine.The expressions of p53 and bcl-2 were not influenced,whereas the expressions of bax and Caspase3 were increased in a time-dependent manner after cells exposure to gemcitabine.The Annexin-V positive cells were significantly increased in dose-dependent way.Conclusions:Gemcitabine could inhibit cell proliferation,especially bladder cancer cells with the phenotype of low grade and shorter doubling time.Gemcitabine could arrest cells at G2/M phase and induce apoptosis possibly through the pathway of bcl-2/bax in bladder cancer cell lines.
Key concepts: Gemcitabine, Apoptosis, Propidium iodide, Flow cytometry, Annexin, Cell cycle, Cytotoxic T cell, Bladder cancer